Tag: CYTR

PHOT, CYTR, RNN & Extended Watchlist

Growlife, Inc. PHOT

We’re looking toward PHOT once again today, this old favorite of ours has provided us with opportinuties on countless occasions, and yesterday the company had some important news hit the wire. The company has enlisted the services of former Microsoft and Yahoo! exec, Marco Hegyi, to serve as Growlife’s President. The company is also set to begin a $40M capital infusion from a Nevada private investment group called CANX USA.

For these reasons, as well as the ripening conditions on the chart, we felt we needed to bring PHOT once again to the foreground of our discussions. We also prepared a video chart presentation for your convenience.

WOODLAND HILLS, Calif., Dec. 11, 2013 /PRNewswire via COMTEX/ — GrowLife, Inc. (OTCBB: PHOT), a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services addressing the needs of legal cannabis growing and retail operations, including hydroponic growing equipment and retail support software, is pleased to announce that effective immediately, Marco Hegyi will assume the position of President and join the Board of Directors.

CytRx Corp. CYTR

CYTR put forth an exciting day of trading yesterday, with the stock undergoing several bounces. The stock opened at 3.90, and hit a subsequent high of 4.39 (+13%). We then saw a pullback to 3.45, and a bounce to 3.74 (+8%). This was followed by bounce from 3.55 to 4.02 (+13%), it pulled back again, and made another swing, this time from 3.60 to 4.05. (+13%)

Flippers certainly had the chance to have a field day with this one, with possible cumulative gains on the order of 47% presenting themselves.

Rexhan Pharmaceuticals, Inc. RNN

RNN came off of yesterday’s extended watchlist to provide our readers with a chance for a nice flip, trading from a low of .4026 to a high of .5179. That move represents an intraday gain of up to 29% on roughly 10X the posted 3mo. average volume.

Extended Watchlist:
OCLS, SNTA, BAXS, ASTC, AVNR
IMUC & SYN – Big gap downs, looking for possible bounces

BGMD, CYTR, ECTE, NRF, SIOCF & Extended Watchlist

BG Medicine, Inc. BGMD

BGMD helped us toward an extremely successful day of trading on Tuesday, and for the second day in a row, the number one spot of all newsletters on the Penny Stock Rumble.

After briefly touching a low of .6115, the stock exploded to a subsequent high of 1.29, marking a possible gain of up to 111% for sharp traders. This happened on more than 33x the 3mo. average volume, qualifying BGMD for momentum-mover status.

We’ll definitely want to follow the activity on this play today, it appears to want to gap up this morning, and could still have added gains in store for us.

Big Volume News Plays

The following three picks come off of our pre-market scanner with news out today, and we wanted to radar them. As we’ve shown with the past couple of days, our scans routinely reveal hidden gems that can provide us with an edge. We’ve taken the Penny Stock Rumble two days in a row, now let’s see that hat-trick!

CytRx Corp. CYTR
Reporting Highly Statistically Significant Positive Results from its Global Phase 2b Clinical Trial  >>>FULL PR

Echo Therapeutics, Inc. ECTE
Echo to receive a $10 million cash investment from MTIA and Platinum Partners –Company will withdraw the offering identified in recent Form S-1 filing>>>FULL PR

Northstar Reality Finance Corp. NRF
NorthStar Realty Finance announces plan to spin-off Asset Management Business into a separate publicly traded company in a tax-free transaction >>>FULL PR

Sierra Iron Ore Corp. SIOCF

While we have not been paid on SIOCF, we are aware of a paid promotion currently underway on the stock, so we thought we’d share that info.

Aside from that, the stock shows a chart that is looking ripe for a possible move. The accumulation/distribution has reached all-time highs, the RSI is coming off of being oversold, and is pushing through the 50-line. The MACD has also undergone a bullish cross.

Extended Watchlist:
GRPN, LIVE, OREX, ARIA, FREE,

TSLA, PLUG, ETRM, OMED & Extended Watchlist

Tesla Motors, Inc. TSLA – Options
–
Back on November 29th, we were noticing that conditions on the TSLA chart had been exhibiting signs of a coming uptrend, and as a result, we presented a few options trading ideas that we felt had a reasonable chance of success. In particular, the 12/21 $120 Calls, and the 12/27 $130 Calls. We were rewarded for our interest, as the stock did indeed find its legs and begin to run following that report.

Since then we’ve seen some major moves out of those contracts, as the $120 Calls ended up trading from a low of 8.40, all the way up to yesterday’s closing price of 25.46, a monstrous 203% gain. The $130 Calls saw their low at 5.03, and ended up closing at 17.07. That was good for an even larger 239% rip.

Chartwise, it appears as if resistance is sitting at $145.65, $151, and the 50DMA of $159.45, and there is a gap on the chart to fill from $160-176, so a push past those key resistance points could lead to more pronounced increases. We would continue to take advantage of the added gains on these contracts, and in the event of a sustained uptrend, would have to consider rolling our strike price up to higher level that we believe would still be pushed into the money.

Plug Power, Inc. PLUG

PLUG has been an old favorite of ours from last March when we caught it on our scanners coming off its 52-wk lows (.1155) and we’ve mentioned it on multiple occasions since that time. We’ve followed this play all the way up to current levels, which as a result of recent favorable reports on the company’s finances, have reached all the way up to this morning’s pre-market high of 1.41. That represents an increase of 1121% off of lows following our initial alert.

We’ll be continuing to monitor PLUG closely, and will certainly want to take part in today’s conference call/webcast in which the CEO will address the reasoning behind his statement that the company is on pace for a “blowout quarter.”, as well as other issues.

LATHAM, N.Y., Dec 04, 2013 (GLOBE NEWSWIRE via COMTEX) — Plug Power Inc. (Nasdaq:PLUG), a leader in providing clean, reliable energy solutions, will today host a conference call and webcast during which CEO Andy Marsh will provide a business update for Plug Power and the Company’s expectations for the remainder of 2013 and for 2014.Since the October 8 business update call, the Company has seen an additional 17.8M USD in bookings. Plug Power is currently in negotiations with several large customers on sales agreements to deploy turn-key GenDrive solutions at multiple distribution centers. The Company believes this will significantly impact the fourth quarter bookings, as well as provide a recurring revenue stream from product, service and hydrogen contracts. Plug Power expects orders to range between 30M and 40M USD for the fourth quarter of 2013.

Plug Power has scheduled its conference call and webcast today at 10:30 am ET to review the Company’s business updates. Participants are encouraged to join the webcast to access the accompanying slide show presentation. The webcast can be accessed by going directly to the Plug Power Web site (www.plugpower.com) and selecting the webcast link on the home page. You can also call-in by dialing 877.407.8291. Andy Marsh will be joined by COO, Keith Schmid, and Vice President of Sales, Erik Hansen, to answer questions.

EnteroMedics, Inc. ETRM

ETRM was part of yesterday’s Extended Watchlist, and the stock went on to put up quite a performance. After touching a low of 1.48 shortly before 10:30am, ETRM would spend the rest of the day pressing upward to its high of day and closing price at 2.24. This marks an impressive intraday run of 51% on nearly 20x its 3mo. average volume.

We’ll certainly want to keep an eye on a stock with current momentum of this magnitude.

OncoMed Pharmaceuticals, Inc. OMED

Another winner from yesterday’s Extended Watchlist, OMED traded in a range from 22.10-31.99, which marks an intraday move of 45% Quite an impressive feat for a big-board stock in this price range.

Congrats to anyone who caught this, or any of the opportunities for significant profits afforded by the excellent calls in yesterday’s report.

Extended Watchlist:
IACH, BLDP, FCEL, CCXI, ABIO, IMMU, CPST, RAD, ICLD, CYTR,
HEM (Recently coming off 52week lows),
OCLS (FDA Approval news out this am)